ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

MTNB Matinas Biopharma Holdings Inc

0.1825
0.005 (2.82%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Matinas Biopharma Holdings Inc MTNB AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
0.005 2.82% 0.1825 10:00:00
Open Price Low Price High Price Close Price Previous Close
0.18 0.1716 0.1825 0.1767 0.1775
more quote information »

Recent News

Date Time Source Heading
10/5/202406:06EDGAR2Form 8-K - Current report
10/5/202406:05GLOBEMatinas BioPharma Reports First Quarter 2024 Financial..
10/5/202406:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:00GLOBEMatinas BioPharma’s LNC Platform for the Delivery of Small..
02/5/202421:00GLOBEMatinas BioPharma to Webcast Conference Call to Discuss..
30/4/202422:00GLOBEIn Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in..
03/4/202423:30GLOBEMatinas BioPharma Prices $10 Million Registered Direct..
28/3/202407:05GLOBEMatinas BioPharma Reports 2023 Financial Results and..
25/3/202423:00GLOBEMatinas BioPharma Announces Positive in vivo Safety Data..
23/3/202400:15GLOBEThree Patients with Invasive Fusarium Infection in Matinas..
22/3/202421:30GLOBEMatinas BioPharma Regains Compliance with NYSE American..
27/2/202400:05EDGAR2Form 8-K - Current report
27/2/202400:00GLOBEMatinas BioPharma Provides Positive Outcomes Update on the..
20/2/202423:35EDGAR2Form 8-K - Current report
20/2/202423:30GLOBEMatinas BioPharma Successfully Reaches Agreement with FDA..
09/1/202423:30EDGAR2Form 8-K - Current report
03/1/202423:00GLOBEMatinas BioPharma to Present at Biotech Showcase 2024
27/12/202323:40EDGAR2Form 8-K - Current report
27/12/202323:30GLOBEMatinas BioPharma Demonstrates in vivo Biological Activity..
21/12/202323:40EDGAR2Form 8-K - Current report
21/12/202323:30GLOBEMatinas BioPharma Provides Update to MAT2203 Regulatory and..
16/12/202313:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202313:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202313:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202313:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202313:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202313:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202323:30EDGAR2Form 8-K - Current report
10/11/202309:25EDGAR2Form 8-K - Current report
09/11/202308:06EDGAR2Form 8-K - Current report
09/11/202308:05GLOBEMatinas BioPharma Reports Third Quarter 2023 Financial..
09/11/202308:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202323:30GLOBEMatinas BioPharma Announces Positive in vivo Efficacy..
04/11/202307:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202308:20EDGAR2Form 8-K - Current report
01/11/202322:00GLOBEMatinas BioPharma to Webcast Conference Call to Discuss..
12/10/202301:25APSBiotech Catches Massive Premarket Bid
11/10/202322:30GLOBEPatient with Candida krusei Infection in Matinas BioPharma’s..
28/9/202321:00GLOBEMatinas BioPharma to Present at Two Investment Conferences..
27/9/202321:00GLOBEMatinas BioPharma to Feature MAT2203 in a Pipeline..
23/9/202307:25EDGAR2Form 8-K - Current report
23/9/202307:25GLOBEMatinas BioPharma Announces Notification of NYSE American..
21/9/202323:35GLOBEDawson James Securities Announces October Date for 8th..
20/9/202321:30EDGAR2Form 8-K - Current report
20/9/202307:25EDGAR2Form DEF 14A - Other definitive proxy statements
09/9/202307:15EDGAR2Form PRE 14A - Other preliminary proxy statements
06/9/202321:00GLOBEMatinas BioPharma to Participate in the H.C. Wainwright..
22/8/202321:30GLOBEMatinas BioPharma Announces Publication of Results from the..
10/8/202306:06EDGAR2Form 8-K - Current report
10/8/202306:05GLOBEMatinas BioPharma Reports Second Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock